<SEC-DOCUMENT>0001193125-23-189253.txt : 20230719
<SEC-HEADER>0001193125-23-189253.hdr.sgml : 20230719
<ACCEPTANCE-DATETIME>20230719084555
ACCESSION NUMBER:		0001193125-23-189253
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230719
FILED AS OF DATE:		20230719
DATE AS OF CHANGE:		20230719

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATS Corp /ATS
		CENTRAL INDEX KEY:			0001394832
		STANDARD INDUSTRIAL CLASSIFICATION:	GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569]
		IRS NUMBER:				980149239
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41713
		FILM NUMBER:		231095642

	BUSINESS ADDRESS:	
		STREET 1:		730 FOUNTAIN STREET NORTH
		STREET 2:		BUILDING #3
		CITY:			CAMBRIDGE
		STATE:			A6
		ZIP:			N3H 4R7
		BUSINESS PHONE:		519 653 6500

	MAIL ADDRESS:	
		STREET 1:		730 FOUNTAIN STREET NORTH
		STREET 2:		BUILDING #3
		CITY:			CAMBRIDGE
		STATE:			A6
		ZIP:			N3H 4R7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ATS Automation Tooling Systems Inc.
		DATE OF NAME CHANGE:	20070328
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d502072d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">RULE&nbsp;13a-16&nbsp;OR&nbsp;15d-16</FONT></FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE
SECURITIES EXCHANGE ACT OF 1934 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of July 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File <FONT STYLE="white-space:nowrap">Number:&nbsp;001-41713</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ATS CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>730 Fountain
Street North </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Building 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, Ontario N3H 4R7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of <FONT STYLE="white-space:nowrap">Form&nbsp;20-F&nbsp;or</FONT> <FONT STYLE="white-space:nowrap">Form&nbsp;40-F.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">Form&nbsp;20-F&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form&nbsp;40-F&nbsp;&nbsp;&#9746;</FONT> </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d502072dex991.htm">Press release dated July&nbsp;19, 2023 </A></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>ATS CORPORATION</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: July&nbsp;19, 2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stewart McCuaig</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Stewart McCuaig</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President, General Counsel</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d502072dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g502072dsp003.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ATS Corporation Acquires Life Science Digitalization Solutions Provider Odyssey </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">07/19/2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CAMBRIDGE, ON / CNW / - ATS Corporation (TSX: ATS)
(NYSE: ATS) (&#147;<B>ATS</B>&#148; or the &#147;<B>Company</B>&#148;) today announced that it has acquired Odyssey Validation Consultants Limited (&#147;<B>Odyssey</B>&#148;), an Ireland-based provider of digitalization solutions for the life
science industry. The financial terms of the transaction were not disclosed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Odyssey will join ATS&#146; Process Automation Solutions
(&#147;<B>PA</B>&#148;) business, a leading provider of automation and digitalization solutions for the process and manufacturing industries. Odyssey&#146;s strong focus on supporting customers in the life science industry in their compliant digital
transformation and journey to cloud, will help accelerate PA&#146;s strategy to drive validated production process improvements through digital solutions. This acquisition allows PA to expand its value proposition in the highly attractive life
science <FONT STYLE="white-space:nowrap">end-market</FONT> through delivering qualified and validated digitalization and automation solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Odyssey&#146;s strong expertise in computer system validation and cloud-based software solutions can be offered to our existing customers in the life
science industry as a <FONT STYLE="white-space:nowrap">value-add</FONT> to our current platform, AI and <FONT STYLE="white-space:nowrap">ML-based</FONT> software solutions, advanced data analytics capabilities, and domain knowledge,&#148; said
Dr.&nbsp;Christian Debus, President of PA. &#147;Together we can leverage our capabilities and solutions to drive continuous improvement in regulated production processes for our customers across all industry sectors. We welcome the Odyssey team to
PA.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Digital transformation is playing a key role in accelerating the delivery of new and innovative treatments for patients, with compliance
being key for patient safety, product quality, and data integrity,&#148;&#146; said Oisin Curran&nbsp;&amp; Fionnan Friel, Founders of Odyssey. &#147;Combining our people and products with that of PA Solutions, along with their global reach, can
enable us to accelerate digital transformation in the life science industry and shorten time to market for new treatments for patients.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About
Odyssey </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Founded in 2015 and based in Kildare, Ireland, Odyssey is a provider of digitalization solutions for the life science industry with a strong
focus on computer system validation, facilitating the journey to cloud through fully compliant cloud-based platforms and compliant <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#145;fit-for-purpose&#146;</FONT></FONT> software
solutions. Visit the company&#146;s websites at <U>https://www.odysseyvc.com</U> and <U>https://www.compliantcloud.com</U> for more details. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g502072dsp003.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Process Automation Solutions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Process Automation Solutions GmbH is one of the leading, manufacturer-independent suppliers of complete automation solutions for the process, manufacturing,
and automotive industries. As a strong partner, PA&#146;s 1,400 automation experts in Europe, America, and Asia support their customers during all phases of automation from planning to implementation and commissioning &#150; and if desired,
throughout the entire lifecycle of the plant through aftersales service. Visit PA&#146;s website at&nbsp;<U><FONT STYLE="white-space:nowrap">www.pa-ats.com</FONT></U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ATS Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATS Corporation is an
industry-leading automation solutions provider to many of the world&#146;s most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added services
including <FONT STYLE="white-space:nowrap">pre-automation</FONT> and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, food&nbsp;&amp;
beverage, transportation, consumer products, and energy. Founded in 1978, ATS employs over 6,500 people at more than 60 manufacturing facilities and over 80 offices in North America, Europe, Asia, and Oceania. The Company&#146;s common shares are
traded on the Toronto Stock Exchange and the New York Stock Exchange under the symbol ATS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable
securities laws (&#147;forward-looking statements&#148;). Forward-looking statements include all statements that are not historical facts regarding possible events, conditions or results of operations that ATS believes, expects or anticipates will
or may occur in the future, including, but not limited to: the acceleration of PA&#146;s strategy; the expansion of PA&#146;s value proposition; PA and Odyssey&#146;s ability to leverage their capabilities and solutions to drive continuous
improvement in regulated production processes; and the ability of both PA and Odyssey together to accelerate digital transformation in the life sciences industry and shorten time to market for new treatments. Forward-looking statements are
inherently subject to significant uncertainties, risks, and other factors that could cause the actual results, performance, or achievements of ATS, or developments in ATS&#146; business or in its industry, to differ materially from those discussed
in the forward-looking statements. Important factors that could cause actual results to differ materially from expectations include, but are not limited to, the impact of regional or global conflicts; general market performance including capital
market conditions and availability and cost of credit; performance of the markets that ATS serves; industry challenges in securing the supply of labour, materials, and, in certain jurisdictions, energy sources such as natural gas; impact of
inflation; interest rate changes; foreign currency and exchange risk; the relative strength of the Canadian dollar; risks related to customer concentration; risks related to a recession, slowdown, and/or sustained downturn in the economy; impact of
factors such as increased pricing pressure, increased cost of energy and supplies, and delays in relation thereto, and possible margin compression; the regulatory and tax environment; the emergence of new infectious diseases and pandemics, including
the potential resurgence of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and/or new strains of <FONT STYLE="white-space:nowrap">COVID-19</FONT> and collateral consequences thereof, including the disruption of economic activity, volatility in
capital and credit markets, and legislative and regulatory responses; the effect of events involving limited liquidity, defaults, <FONT STYLE="white-space:nowrap">non-performance</FONT> or other adverse developments that affect financial
institutions, transaction counterparties, or other companies in the financial services industry generally, or concerns or rumours about any events of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g502072dsp003.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">these kinds or other similar risks, that have in the past and may in the future lead to market-wide liquidity
problems; energy shortages and global prices increases; that expectations in relation to the acceleration of PA&#146;s strategy or the expansion of PA&#146;s value proposition are not realized as expected or at all; that the acquisition does not
succeed in leveraging the capabilities of PA and Odyssey to drive continuous improvement as expected or at all; that PA and Odyssey are unable to accelerate digital transformation in the life sciences industry or shorten time to market for new
treatments as expected or at all; and other risks and uncertainties detailed from time to time in ATS&#146; filings with securities regulators, including, without limitation, the risk factors described in ATS&#146; annual information form for the
fiscal year ended March&nbsp;31, 2023, which are available on the System for Electronic Document Analysis and Retrieval (&#147;SEDAR&#148;) and can be accessed at www.sedar.com. ATS has attempted to identify important factors that could cause actual
results, performance, or achievements to vary from those current expectations or estimates expressed or implied by the forward-looking statements. However, there may be other factors that cause results, performance, or achievements not to be as
expected or estimated and that could cause actual results, performance, or achievements to differ materially from current expectations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking
statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management&#146;s current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company&#146;s
business and operations; the ability of ATS to execute on its business objectives; and general economic and political conditions, and global events, including the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Forward-looking statements included in this press release are only provided to understand management&#146;s current expectations relating to future periods
and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be
placed on such statements. ATS does not undertake any obligation to update forward-looking statements contained herein other than as required by law. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For more information, contact:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David
Galison</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Head of Investor Relations</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATS Corporation</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">730 Fountain Street North</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cambridge, ON, N3H 4R7</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(519) <FONT STYLE="white-space:nowrap">653-6500</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">dgalison@atsautomation.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For general media inquiries, contact:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Matthew Robinson</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director, Corporate Communication</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ATS Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">730 Fountain Street North</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cambridge, ON, N3H 4R7</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(519)
<FONT STYLE="white-space:nowrap">653-6500</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">mrobinson@atsautomation.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOURCE: ATS Corporation </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g502072dsp003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g502072dsp003.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M%VZUV]GT#0IGM]*@<I-,APUPP.#R.B>W?OZ4 >.T % "JS(X9&*LIR"#@@T
M>^_"+XR7MQJ%EX8\1N)EEQ%:WK'Y]W\*N>^>@/7.,YSD 'T#0!QFI^&;^[TT
M0P+&DZ:K)>QL6X7&\QD_\"*\4 7?"VBZAIM_J=_J3*USJ(CEE*MD*_S90>RJ
M44'OMS0!TU !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M9LT'_H.:A_WRG^% '6V?AB'X:?"[7[73;R:?RK>XNDDDP&#>5QT_W10!\?4
M>E_!GP%I_C?Q!=MJQWV%A&K/ KE6E9B0!D<X&#G'M0![]+\(O 4L/E-X;MPN
M,95W5OS#9H \,^)WPAO/#6MV[^'+.ZOM.O21'%&C2R0N.JG Y'<'Z^F2 4M#
M^"'CO4)(IC91Z8H(99;F8*5]]JY8'\* /JG1X;^WT:SAU2X2XOXXE6>9!A9'
M Y8#WH NT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M#<R77PIT"24Y986C'T5V4?H!0!VU !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MQD?C0!]PZ;?P:KI=IJ%JVZWNHEFC/JK $?SH \W^/_\ R3"3_K[B_K0!\I4
M?6_P)_Y)1IW_ %UF_P#1C4 >D4 8/C3P\/%7@[4]%RJO<PD1LW0.#N4G_@0%
M 'Q+>V5SIM]/97D+0W,#F.2-A@JP."* -#P_XGUKPK?"\T74);27^(*<JX]&
M4\$?6@#TU/VC_%*P!6TO2VD QOV2#/X;Z /-_%/B[6?&6J?VAK-UYL@&V.-1
MM2)?11V_GZT 95G9SZA?065K&9;BXD6.-!U9B< ?F: /MSP=H3>&?!^E:,[J
M\EI $D9>A?JV/;)- &Y0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 8WBR+4Y_"VH6^CQ>9?S1>7&-X7&[@G)
M/& 2:ZL&Z4:\95G[J=R*G,XM1W/ _P#A4?C/_H&)_P"!,?\ \57VG]M8+^;\
M'_D>=]7J=@_X5'XS_P"@8G_@3'_\51_;6"_F_!_Y!]7J=@_X5'XS_P"@8G_@
M3'_\51_;6"_F_!_Y!]7J=C9\*?"?Q!#XHT^?6+%(K"&422'SD;.WD# )ZD 5
MR8S.,/*A*-&7O-6V9=/#S4DY+0]@\6VNHWOAZ>STR+S)YR$;Y@N%[]?IC\:^
M9P,Z5.NIU7HOS.K$1G*FXP/,/^%>^)?^?%?^_P G^-?2_P!JX7^;\&>5]3K=
M@_X5[XE_Y\5_[_)_C1_:N%_F_!A]3K=@_P"%>^)?^?%?^_R?XT?VKA?YOP8?
M4ZW8W/"7@;5++Q#!=ZG;+'!!EQ^\5LMVZ'\?PKBQV94:E!PI/5_D;X?"SC44
MIK1'<>(;:\O=/%O9Q[MS O\ ,!P/K[XKQ<).G3GS39WUHRE&T3EO^$8U;_GW
M'_?Q?\:]/Z[1[G)["IV#_A&-6_Y]Q_W\7_&CZ[1[A["IV#_A&-6_Y]Q_W\7_
M !H^NT>X>PJ=C7\/:#=66H&XO(@@13L^8'D_3VS7+B\5"<.6#-J-*497D=37
MEG6>#_&'P'XV\:^+HYM-TU9=,M(%C@)N(UW$\L<%LCDX_P" B@#ST? SX@9_
MY \8_P"WN+_XJ@#ZH\/:/#X?\.Z?I,  CM(%BR.Y Y/XG)_&@#2H * /+/C3
M\/+SQGI=C=Z-;";5K1]FPR*@>)NO+$#@@$<]S0!XM_PH_P"(/_0#7_P+A_\
MBJ /H;X4Z;X@T3P-;Z3XBM?L]S9R-'$/-5]T75>5)Z$D?0"@"+XN^&M4\5^!
M7TS1[<3W9N(W"%U3@9SR2!0!X!_PHSX@?] >/_P+B_\ BJ /H;X4^']2\+^
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0_\ H8?_ "3@_P#B* #_ (7;\0_^AA_\DX/_ (B@ _X7;\0_^AA_\DX/_B*
M/1_@I\1/%7B[QE>6&N:I]KM8[!YE3R(DPXDC .54'HQ_.@#WB@ H * "@ H
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M&<\>N#Z4 <__ ,+3_P"I"\9_^"G_ .RH /\ A:?_ %(7C/\ \%/_ -E0 ?\
M"T_^I"\9_P#@I_\ LJ #_A:?_4A>,_\ P4__ &5 !_PM/_J0O&?_ (*?_LJ
M#_A:?_4A>,__  4__94 '_"T_P#J0O&?_@I_^RH /^%I_P#4A>,__!3_ /94
M '_"T_\ J0O&?_@I_P#LJ #_ (6G_P!2%XS_ /!3_P#94 '_  M/_J0O&?\
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M /\ A:?_ %(7C/\ \%/_ -E0 ?\ "T_^I"\9_P#@I_\ LJ #_A:?_4A>,_\
MP4__ &5 !_PM/_J0O&?_ (*?_LJ #_A:?_4A>,__  4__94 '_"T_P#J0O&?
M_@I_^RH /^%I_P#4A>,__!3_ /94 '_"T_\ J0O&?_@I_P#LJ #_ (6G_P!2
M%XS_ /!3_P#94 '_  M/_J0O&?\ X*?_ +*@ _X6G_U(7C/_ ,%/_P!E0 ?\
M+3_ZD+QG_P""G_[*@ _X6G_U(7C/_P %/_V5 !_PM/\ ZD+QG_X*?_LJ #_A
M:?\ U(7C/_P4_P#V5 !_PM/_ *D+QG_X*?\ [*@ _P"%I_\ 4A>,_P#P4_\
MV5 !_P +3_ZD+QG_ ."G_P"RH /^%I_]2%XS_P#!3_\ 94 '_"T_^I"\9_\
M@I_^RH /^%I_]2%XS_\ !3_]E0 ?\+3_ .I"\9_^"G_[*@ _X6G_ -2%XS_\
M%/\ ]E0 ?\+3_P"I"\9_^"G_ .RH /\ A:?_ %(7C/\ \%/_ -E0 ?\ "T_^
MI"\9_P#@I_\ LJ #_A:?_4A>,_\ P4__ &5 !_PM/_J0O&?_ (*?_LJ #_A:
M?_4A>,__  4__94 '_"T_P#J0O&?_@I_^RH /^%I_P#4A>,__!3_ /94 '_"
MT_\ J0O&?_@I_P#LJ #_ (6G_P!2%XS_ /!3_P#94 '_  M/_J0O&?\ X*?_
M +*@ _X6G_U(7C/_ ,%/_P!E0!Y!\<_%7_"3?V#_ ,2'6=*^S^?_ ,A.T\CS
M-WE_<Y.<;>?3(H \?H * "@ H * "@ H * "@ H * "@ H ]4^$&L-H&C>,=
M46%)_LUI$[1./E==^"I^HR*N;2H^]LY)/YDQ3=96WM+\+'?:+I.FZ;IWAZZT
M682:3J7B2.[M1GF)6A8&,^ZL"*;O&4*<ND9Z]U9M,)24Z<YI6OR:=GS*YXOK
M.I:%::W=W&FZ;J4&HPW9DCFEU".2,,KYSL$*GM_>_.L<-+D4)+96-:\5*4XR
MZW/8[F[L- U6'4R$-OXWO(MW3BW: !\CM^\ES^%:.EJ\)_B?_P B0JC4?K/5
M**]&GK^",RZDU#PK?0^%['23JMII.B-'J4=O.(IE\Y]SNAZDC"] >M3*:J*;
ME\/NKTLO^'\A\OLW%1WO)J_5;+YV_P" <3XLMK:3X;:1>Z-J.HMHB7KPQ6>I
M11^9&^W)9)%'S)VQTS2J*2G'FZK3TOU_04+<LDM-5<U6TW1-5\(?#RUU;7)]
M)9UN%CF2U$B#]]_$V]2G.,'!Z\XKHDKXC3?EC^73S,D[4G?:[_0W_%%W$]CX
M_P#[:TJ[6&!]/A\M+A8Y90N0LA?:X.>O0\5SMITXR>[G+3MHC:W++E3NE%:]
M]3E/!4NERZ3XU.E6=W:QC0I=ZW-TLY)W#H5C3'Y&JG?V$O\ %'\V9JWMX^DO
MR14^'#6R>'/&[7D,LUN--7>D4HC=AY@Z,58#\C2J6]CK_-']1PO[=6_EE^A4
M\):1H?B7QEIMM9V-Y9V,!:XOGNKQ)P(D^8_=C3'3'?J*TIOD;J/:*O\ /I^(
MJBYH\D=Y.W^9Z'JUS+XQBTSQ)H5U8:QK&C:O@11EXU,$C[HD;S53&"-OISUJ
M*:E3G"HE>Z:?JD_T*FXSC.GLE9KTT7YV;,F?R-8MO&CZ>VL:)J@@:?5+*]"7
M%L^&Y0.5W*W]T_EQ2II*$7'6/-'UO?\ J_XEZNK[VDK/^OZV_/*^*-QX=C\=
M7J7NEZE-=^3!F2'4(XT/[I<?(86/I_%^52_BG;N_S&OX=._\J/,*H@]@_9Q_
MY*'J'_8+D_\ 1L5 'T_0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!X!^TU_S*W_;U_[2H ^?
MZ "@ H * "@ H * "@ H * "@ H * +%O?WEI!<06UW/##<J$FCCD*K*H[,!
MU'UH>JLP6CNB>VUS5K*"&"UU2\@AAE\Z..*=E5),8W@ \-CN.:=WH^PK+5=R
MY<^,?%%[;26UUXDU6>WE4J\4M[(RN#U!!."*EI/<:=MC.GU*^N8K:*XO;B6.
MU7; KRLPB'HH)^4?2JNU+FZBLK<O0E77-775#JBZI>#43UNA.WFGC'W\YZ#U
MI+W=AM7M?H)J6M:KK,B/JFIW=\\8PC7,[2%1[;B<4K+<=WL037MW<6UO;374
MTD%N"(8W<E8P3D[0>!D\\4V[N[W%MH:<7C#Q/;OOA\1ZK&VQ8\I>R [5SM7@
M]!DX';--MO<25DDN@\^-O%9F68^)]7,JJ5#_ &Z7(!QD9W=.!^5+88?\)KXK
M\\3_ /"3:OYP78'^W2[@N<XSNZ<4; ,N?%_B:]A>&Z\1:I/$ZE&26\D964]0
M03R#2:3W&FUL9]IJ5_81S1V=[<6\<X"RK%*R"0 Y 8 \_C57TL39%N]\3^(-
M3M/LE_KFHW=MQ^YGNG=..G!.*76_4:T5D6E\<^+D4*OBG60H& !?RX _[ZH>
MNX)6T1A.[R2,[L6=CEF8Y)/J:222LAMMN[/7OV<?^2AZA_V"Y/\ T;%3$?3]
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % 'A_[0^A:QK?_".?V3I5[?\ D_:?,^RV[R[,^5C.
MT'&<'\C0!XA_P@GC#_H5-9_\ )?_ (F@ _X03QA_T*FL_P#@!+_\30 ?\()X
MP_Z%36?_   E_P#B: #_ (03QA_T*FL_^ $O_P 30 ?\()XP_P"A4UG_ , )
M?_B: #_A!/&'_0J:S_X 2_\ Q- !_P ()XP_Z%36?_ "7_XF@ _X03QA_P!"
MIK/_ ( 2_P#Q- !_P@GC#_H5-9_\ )?_ (F@ _X03QA_T*FL_P#@!+_\30 ?
M\()XP_Z%36?_   E_P#B: #_ (03QA_T*FL_^ $O_P 30 ?\()XP_P"A4UG_
M , )?_B: #_A!/&'_0J:S_X 2_\ Q- !_P ()XP_Z%36?_ "7_XF@ _X03QA
M_P!"IK/_ ( 2_P#Q- !_P@GC#_H5-9_\ )?_ (F@ _X03QA_T*FL_P#@!+_\
M30 ?\()XP_Z%36?_   E_P#B: #_ (03QA_T*FL_^ $O_P 30 ?\()XP_P"A
M4UG_ , )?_B: #_A!/&'_0J:S_X 2_\ Q- !_P ()XP_Z%36?_ "7_XF@ _X
M03QA_P!"IK/_ ( 2_P#Q- !_P@GC#_H5-9_\ )?_ (F@ _X03QA_T*FL_P#@
M!+_\30 ?\()XP_Z%36?_   E_P#B: #_ (03QA_T*FL_^ $O_P 30!ZI\ O#
M6O:-XZOKC5-$U"Q@;3G19+FU>-2WF1G + #. >/:@#Z+H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
..H * "@ H * "@ H _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
